Described herein are pharmaceutical packaging units which prevent oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-delicate medication, these types of devices together with a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with really lower permeability to o